Table 3 Tumor Characteristics
From: Marijuana and head and neck cancer: an epidemiological review
Variable | Non-Marijuana | Marijuana | p-Value |
|---|---|---|---|
N | 805 | 74 | |
Primary Site of Cancer, n (%) | < 0.0001 | ||
Oropharynx | 160 (19.9) | 47 (63.5) | |
Oral Cavity | 141 (17.5) | 14 (18.9) | |
Nasopharynx | 19 (2.4) | 0 (0) | |
Hypopharynx | 12 (1.5) | 1 (1.4) | |
Larynx | 138 (17.2) | 12 (16.2) | |
Skin | 81 (10.1) | 0 (0) | |
Salivary Gland | 76 (9.4) | 0 (0) | |
Other | 177 (22.0) | 0 (0) | |
Oropharynx p16 Status | 0.002 | ||
P16 Positive | 132 (82.5) | 45 (95.7) | |
P16 Negative | 28 (17.5) | 2 (4.3) | |
cT-Stage, n (%) | 0.076 | ||
Tis | 13 (1.6) | 1 (1.4) | |
T1 | 245 (30.4) | 22 (29.8) | |
T2 | 318 (39.5) | 28 (37.8) | |
T3 | 148 (18.4) | 14 (18.9) | |
T4 | 81 (10.1) | 7 (9.6) | |
cN-Stage, n (%) | 0.144 | ||
N0 | 357 (44.4) | 31 (43.0) | |
N1 | 100 (12.4) | 8 (11.1) | |
N2a | 229 (28.4) | 20 (27.8) | |
N2b | 59 (7.4) | 6 (8.3) | |
N2c | 30 (3.7) | 3 (4.2) | |
N3 | 30 (3.7) | 4 (5.6) | |
Treatment, n (%) | < 0.0001 | ||
S | 167 (20.8) | 8 (10.8) | |
RT | 151 (18.8) | 14 (18.9) | |
CRT | 195 (24.2) | 33 (48.6) | |
S-RT | 197 (24.4) | 12 (16.2) | |
S-CRT | 84 (10.4) | 6 (8.1) | |
Palliative | 11 (1.4) | 0 (0) |